138 related articles for article (PubMed ID: 22526314)
1. Pharmacokinetic comparison of a single oral dose of polymorph form i versus form V capsules of the antiorthopoxvirus compound ST-246 in human volunteers.
Chinsangaram J; Honeychurch KM; Tyavanagimatt SR; Bolken TC; Jordan R; Jones KF; Marbury T; Lichtenstein I; Pickens M; Corrado M; Landis P; Clarke JM; Frimm AM; Hruby DE
Antimicrob Agents Chemother; 2012 Jul; 56(7):3582-6. PubMed ID: 22526314
[TBL] [Abstract][Full Text] [Related]
2. Safety and pharmacokinetics of the antiorthopoxvirus compound ST-246 following repeat oral dosing in healthy adult subjects.
Jordan R; Chinsangaram J; Bolken TC; Tyavanagimatt SR; Tien D; Jones KF; Frimm A; Corrado ML; Pickens M; Landis P; Clarke J; Marbury TC; Hruby DE
Antimicrob Agents Chemother; 2010 Jun; 54(6):2560-6. PubMed ID: 20385870
[TBL] [Abstract][Full Text] [Related]
3. Safety and pharmacokinetics of the anti-orthopoxvirus compound ST-246 following a single daily oral dose for 14 days in human volunteers.
Chinsangaram J; Honeychurch KM; Tyavanagimatt SR; Leeds JM; Bolken TC; Jones KF; Jordan R; Marbury T; Ruckle J; Mee-Lee D; Ross E; Lichtenstein I; Pickens M; Corrado M; Clarke JM; Frimm AM; Hruby DE
Antimicrob Agents Chemother; 2012 Sep; 56(9):4900-5. PubMed ID: 22777041
[TBL] [Abstract][Full Text] [Related]
4. Single-dose safety and pharmacokinetics of ST-246, a novel orthopoxvirus egress inhibitor.
Jordan R; Tien D; Bolken TC; Jones KF; Tyavanagimatt SR; Strasser J; Frimm A; Corrado ML; Strome PG; Hruby DE
Antimicrob Agents Chemother; 2008 May; 52(5):1721-7. PubMed ID: 18316519
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the safety and pharmacokinetics of ST-246® after i.v. infusion or oral administration in mice, rabbits and monkeys.
Chen Y; Amantana A; Tyavanagimatt SR; Zima D; Yan XS; Kasi G; Weeks M; Stone MA; Weimers WC; Samuel P; Tan Y; Jones KF; Lee DR; Kickner SS; Saville BM; Lauzon M; McIntyre A; Honeychurch KM; Jordan R; Hruby DE; Leeds JM
PLoS One; 2011; 6(8):e23237. PubMed ID: 21858040
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and interspecies allometric scaling of ST-246, an oral antiviral therapeutic for treatment of orthopoxvirus infection.
Amantana A; Chen Y; Tyavanagimatt SR; Jones KF; Jordan R; Chinsangaram J; Bolken TC; Leeds JM; Hruby DE
PLoS One; 2013; 8(4):e61514. PubMed ID: 23637845
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic properties and bioequivalence of two compound formulations of 1500 mg ampicillin (1167 mg)/probenecid (333 mg): a randomized-sequence, single-dose, open-label, two-period crossover study in healthy Chinese male volunteers.
Wu H; Liu M; Wang S; Feng W; Yao W; Zhao H; Wei M
Clin Ther; 2010 Mar; 32(3):597-606. PubMed ID: 20399996
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic properties and bioequivalence of two formulations of arbidol: an open-label, single-dose, randomized-sequence, two-period crossover study in healthy Chinese male volunteers.
Liu MY; Wang S; Yao WF; Wu HZ; Meng SN; Wei MJ
Clin Ther; 2009 Apr; 31(4):784-92. PubMed ID: 19446151
[TBL] [Abstract][Full Text] [Related]
9. Oral Tecovirimat for the Treatment of Smallpox.
Grosenbach DW; Honeychurch K; Rose EA; Chinsangaram J; Frimm A; Maiti B; Lovejoy C; Meara I; Long P; Hruby DE
N Engl J Med; 2018 Jul; 379(1):44-53. PubMed ID: 29972742
[TBL] [Abstract][Full Text] [Related]
10. Bioequivalence and pharmacokinetic comparison of two mycophenolate mofetil formulations in healthy Chinese male volunteers: an open-label, randomized-sequence, single-dose, two-way crossover study.
Zhang Q; Tao Y; Zhu Y; Zhu D
Clin Ther; 2010 Jan; 32(1):171-8. PubMed ID: 20171422
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and bioequivalence study of valacyclovir hydrochloride capsules after single dose administration in healthy Chinese male volunteers.
Lin H; Tian Y; Tian JX; Zhang ZJ; Mao GG
Arzneimittelforschung; 2010; 60(3):162-7. PubMed ID: 20422949
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and bioequivalence evaluation of two formulations of 10-mg amlodipine besylate: an open-label, single-dose, randomized, two-way crossover study in healthy Chinese male volunteers.
Liu Y; Jia J; Liu G; Li S; Lu C; Liu Y; Yu C
Clin Ther; 2009 Apr; 31(4):777-83. PubMed ID: 19446150
[TBL] [Abstract][Full Text] [Related]
13. A Pharmacokinetic Bioequivalence Study Comparing Pirfenidone Tablet and Capsule Dosage Forms in Healthy Adult Volunteers.
Pan L; Belloni P; Ding HT; Wang J; Rubino CM; Putnam WS
Adv Ther; 2017 Sep; 34(9):2071-2082. PubMed ID: 28808905
[TBL] [Abstract][Full Text] [Related]
14. Molecule of the month. Tecovirimat.
Drug News Perspect; 2008 Nov; 21(9):517. PubMed ID: 19180269
[No Abstract] [Full Text] [Related]
15. Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers.
Boonleang J; Panrat K; Tantana C; Krittathanmakul S; Jintapakorn W
Clin Ther; 2007 Apr; 29(4):703-10. PubMed ID: 17617293
[TBL] [Abstract][Full Text] [Related]
16. Bioequivalence of a single 400-mg dose of imatinib 100-mg oral tablets and a 400-mg tablet in healthy adult Korean volunteers.
Lee HW; Seong SJ; Park SM; Lee J; Gwon MR; Kim HJ; Lim SM; Lim MS; Kim W; Yang DH; Yoon YR
Int J Clin Pharmacol Ther; 2015 Jun; 53(6):480-7. PubMed ID: 25881751
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
18. Bioequivalence studies of two different film-coated tablet formulations of valacyclovir of two different strengths in healthy volunteers.
Neves R; Almeida S; Filipe A; Spinola AC; Abolfathi Z; Lévesque A; Ortuño J; Torns A
Arzneimittelforschung; 2010; 60(5):273-81. PubMed ID: 20533765
[TBL] [Abstract][Full Text] [Related]
19. Single-dose bioequivalence of 105-mg fenofibric acid tablets versus 145-mg fenofibrate tablets under fasting and fed conditions: a report of two phase I, open-label, single-dose, randomized, crossover clinical trials.
Godfrey AR; Digiacinto J; Davis MW
Clin Ther; 2011 Jun; 33(6):766-75. PubMed ID: 21704241
[TBL] [Abstract][Full Text] [Related]
20. Safety and clinical pharmacokinetics of nemonoxacin, a novel non-fluorinated quinolone, in healthy Chinese volunteers following single and multiple oral doses.
Guo B; Wu X; Zhang Y; Shi Y; Yu J; Cao G; Zhang J
Clin Drug Investig; 2012 Jul; 32(7):475-86. PubMed ID: 22650326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
